SOD1 and benign prostatic hyperplasia: In contrast, the BPH group had significantly lower activity in prostatic SOD relative to the control/vehicle group (152.2 ± 62.73 U/g versus 437.6 ± 57.51 U/g, p < 0.001; Figure 2D).